🇺🇸 Technescan Mag3 in United States

FDA authorised Technescan Mag3 on 15 June 1990

Marketing authorisations

FDA — authorised 15 June 1990

  • Application: NDA019882
  • Marketing authorisation holder: CURIUM
  • Local brand name: TECHNESCAN MAG3
  • Indication: INJECTABLE — INJECTION
  • Status: approved

Read official source →

FDA — authorised 12 July 2019

  • Application: ANDA208994
  • Marketing authorisation holder: SUN PHARM INDS INC
  • Local brand name: TECHNETIUM TC99M MERTIATIDE KIT
  • Indication: INJECTABLE — INJECTION
  • Status: approved

Read official source →

FDA

  • Status: approved

Technescan Mag3 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Nephrology approved in United States

Frequently asked questions

Is Technescan Mag3 approved in United States?

Yes. FDA authorised it on 15 June 1990; FDA authorised it on 12 July 2019; FDA has authorised it.

Who is the marketing authorisation holder for Technescan Mag3 in United States?

CURIUM holds the US marketing authorisation.